| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Hydrofarm Holdings Group, Inc.
13G
HYFM · 44888K407
|
9.9% |
11/3/2026
Event 10/27/2026
|
||||
| DG Capital Management, LLC | 9.9% | |||||
| Dov Gertzulin | 9.9% | |||||
| DG Value Partners II Master Fund, LP | 8.9% | |||||
|
Anterix Inc.
13G/A
ATEX · 03676C100
|
4.0% |
11/12/2025
Event 9/30/2025
|
||||
| DG Capital Management, LLC | 4.0% | |||||
| Dov Gertzulin | 4.0% | |||||
|
Fennec Pharmaceuticals Inc.
13G/A
FENC · 31447P100
|
4.1% |
2/14/2025
Event 12/31/2024
|
||||
| DG Capital Management, LLC | 4.1% | |||||
| DG Value Partners II Master Fund, LP | 3.5% | |||||
| Dov Gertzulin | 4.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.